TXN and cancer: TrxR regulates the antioxidant thioredoxin system that controls intracellular ROS levels. Inhibition of TrxR leads to oxidative stress due to attenuation of this cytoprotective system. This mechanism of induction of redox imbalance makes auranofin and other potential TrxR inhibitors attractive as anti-cancer drugs